Phibro Animal Health (PAHC) Income towards Parent Company (2012 - 2026)

Phibro Animal Health has reported Income towards Parent Company for 15 years, with the latest figure at $21.7 million in Q2 2026.

• On a quarterly basis, Income towards Parent Company rose 74.08% year-over-year to $21.7 million in Q2 2026; TTM through Jun 2026 was $99.7 million, a 129.18% increase from a year earlier, with the FY2026 full-year figure at $99.7 million, up 129.18% from the prior year.
• Income towards Parent Company was $21.7 million for Q2 2026 at Phibro Animal Health, down from $24.0 million in the prior quarter.
• The five-year high for Income towards Parent Company was $27.5 million in Q4 2025, with the low at -$8.0 million in Q3 2023.
• Average Income towards Parent Company over 5 years is $11.7 million, with a median of $9.3 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Income towards Parent Company sank 307.86% in 2023, then jumped 762.14% in 2025.
• Over 5 years, Income towards Parent Company stood at $7.2 million in 2022, then slumped by 82.33% to $1.3 million in 2023, then surged by 150.0% to $3.2 million in 2024, then jumped by 762.14% to $27.5 million in 2025, then dropped by 20.94% to $21.7 million in 2026.
• The last three Income towards Parent Company figures came in at $21.7 million (Q2 2026), $24.0 million (Q1 2026), and $27.5 million (Q4 2025), per Business Quant data.